The Informatics Core develops and supports informatics applications and shared informatics resources forCancer Center investigators. Many Cancer Center programs and cores have projects requiring complexinformation systems, including tissue and specimen tracking, related clinical and patient follow-upinformation, clinical trials data management, microarray data and metadata management and analysis.
The aims of the Core are to develop, deploy, and maintain data systems and applications to directly supportthe translational research goals of the Center. The Core develops data systems that span a range of users,from individual investigators, to individual programs within the Cancer Center, and to the Cancer Center as awhole. It works with researchers, Cancer Center administration, and other cores to fulfill its goals.Services of the Core include: (1) design and implementation of data models, (2) design and implementationof user interfaces, (3) maintenance of databases and associated web sites, and (4) custom data servicesinvolving specific programming expertise. These capabilities are offered on a recharge basis, both for shortand long-term projects.PERFORMANCE SITE(S) (organization, city, state)UCSF Comprehensive Cancer CenterSan Francisco, CaliforniaPHS 398 (Rev. 04/06) - Page 2 Form Page 2PHS 398/2590 (Rev. 09/04) Page 1 1 O 1 Informatics

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082103-09
Application #
7506559
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-09-25
Project End
2012-05-31
Budget Start
2007-09-25
Budget End
2008-05-31
Support Year
9
Fiscal Year
2007
Total Cost
$399,244
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607
An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794
Olshen, Adam; Wolf, Denise; Jones, Ella F et al. (2018) Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL. J Med Imaging (Bellingham) 5:011014
Li, Megan; Kroetz, Deanna L (2018) Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacol Ther 182:152-160
Brunner, Katja; John, Constance M; Phillips, Nancy J et al. (2018) Novel Campylobacter concisus lipooligosaccharide is a determinant of inflammatory potential and virulence. J Lipid Res 59:1893-1905
Felix, Janine F; Joubert, Bonnie R; Baccarelli, Andrea A et al. (2018) Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium. Int J Epidemiol 47:22-23u
Cobler, Lara; Zhang, Hui; Suri, Poojan et al. (2018) xCT inhibition sensitizes tumors to ?-radiation via glutathione reduction. Oncotarget 9:32280-32297
Li, Megan; Mulkey, Flora; Jiang, Chen et al. (2018) Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res 24:4734-4744
Ryu, Jae Kyu; Rafalski, Victoria A; Meyer-Franke, Anke et al. (2018) Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol 19:1212-1223
Zhou, Yu; Zou, Hao; Yau, Christina et al. (2018) Discovery of internalizing antibodies to basal breast cancer cells. Protein Eng Des Sel 31:17-28

Showing the most recent 10 out of 192 publications